Female patients with DLBCL and involvement of the reproductive organs have poor outcomes and markedly increased risk of central nervous system relapse with R-CHOP(-like) therapy

Autor: El-Galaly, Tarec Christoffer, Cheah, CY, Hutchings, M., Sehn, L, Hansen, JW, Poulsen, Mette Østergaard, Rady, K, Juul Mylam, Karen, Larsen, Thomas Stauffer, Holmberg, S., Juul, Maja Bech, Bech, Sabrina Cordua, Clausen, M R, Jensen, K.B., Bøgsted, Martin, Johnsen, H.E., Seymour, JF, Connors, JM, Brown, Peter de Nully, Villa, D

Publikováno v: El-Galaly, T C, Cheah, CY, Hutchings, M, Sehn, L, Hansen, JW, Poulsen, M Ø, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Bech, S C, Clausen, M R, Jensen, K B, Bøgsted, M, Johnsen, H E, Seymour, JF, Connors, JM, Brown, P D N & Villa, D 2015, ' Female patients with DLBCL and involvement of the reproductive organs have poor outcomes and markedly increased risk of central nervous system relapse with R-CHOP(-like) therapy ', Hematological Oncology
, vol. 33, no. S1, pp. 209-11 . https://doi.org/10.1002/hon.2228
El-Galaly, T C, Cheah, CY, Hutchings, M, Sehn, L, Hansen, JW, Poulsen, M Ø, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Bech, S C, Clausen, M R, Jensen, K B, Bøgsted, M, Johnsen, H E, Seymour, JF, Connors, JM, Brown, P D N & Villa, D 2015, ' Female patients with DLBCL and involvement of the reproductive organs have poor outcomes and markedly increased risk of central nervous system relapse with R-CHOP(-like) therapy ', 13th International Conference on Malignant Lymphoma, Lugano, Switzerland, 17/06/2015-20/06/2015 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aead560bc2367913bf7cf9ed5346b35c
https://portal.findresearcher.sdu.dk/da/publications/f9ed6297-0438-4e93-9e71-65dee224bb3c

Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.

Autor: Abramson JS; Massachusetts General Hospital Cancer Center, Boston, MA, USA. Electronic address: jabramson@mgh.harvard.edu., Ku M; St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia., Hertzberg M; Department of Haematology, Prince of Wales Hospital and UNSW, Sydney, NSW, Australia., Huang HQ; Sun Yat-sen University Cancer Center, Guangzhou, China., Fox CP; School of Medicine, University of Nottingham, Nottingham, UK., Zhang H; Tianjin Medical University Cancer Institute, Tianjin, China., Yoon DH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Kim WS; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Abdulhaq H; Department of Medicine, University of California San Francisco, Fresno, CA, USA., Townsend W; Research Department of Haematology, University College London Hospitals, London, UK., Herbaux C; Clinical Haematology, University Hospital of Montpellier, Montpellier, France., Zaucha JM; Department of Haematology and Transplantology, Medical University of Gdańsk, Gdańsk, Poland., Zhang QY; Harbin Medical University Cancer Hospital, Harbin, China., Chang H; Chang Gung Medical Foundation - Linkou Branch, Taoyuan City, Taiwan., Liu Y; Henan Cancer Hospital, Zhengzhou, China., Cheah CY; Sir Charles Gairdner Hospital, Linear Clinical Research and University of Western Australia, Perth, WA, Australia., Ghesquieres H; Hôpital Lyon Sud - Hospices Civils de Lyon, Lyon, France., Simko S; Genentech, San Francisco, CA, USA., Orellana-Noia V; Genentech, San Francisco, CA, USA., Ta R; Genentech, San Francisco, CA, USA., Relf J; Roche Products, Welwyn Garden City, UK., Dixon M; Roche Products, Welwyn Garden City, UK., Kallemeijn M; F Hoffmann-La Roche, Basel, Switzerland., Mulvihill E; F Hoffmann-La Roche, Basel, Switzerland., Huang H; F Hoffmann-La Roche, Mississauga, ON, Canada., Lundberg L; F Hoffmann-La Roche, Basel, Switzerland., Gregory GP; School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.

Publikováno v: Lancet (London, England) [Lancet] 2024 Nov 16; Vol. 404 (10466), pp. 1940-1954.

Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study.

Autor: Verner E; Department of Haematology, Concord Repatriation General Hospital, NSW, Australia.; Faculty of Medicine & Health, The University of Sydney, NSW, Australia., Johnston A; Faculty of Medicine & Health, The University of Sydney, NSW, Australia.; Department of Haematology, Westmead Hospital, NSW, Australia., Pati N; Department of Haematology, The Canberra Hospital, ACT, Australia.; School of Medicine & Psychology, Australian National University, ACT, Australia., Hawkes EA; Department of Oncology, Eastern Health, VIC, Australia.; Olivia Newton-John Cancer Research Institute at Austin Health, VIC, Australia.; School of Public Health and Preventive Medicine, Monash University, VIC, Australia., Lee HP; Department of Haematology, Flinders Medical Centre, SA, Australia., Cochrane T; Department of Haematology, Gold Coast University Hospital, QLD, Australia.; School of Medicine and Dentistry, Griffiths University, QLD, Australia., Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, WA, Australia.; Department of Haematology, PathWest Laboratory Medicine, WA, Australia.; Faculty of Health & Medical Sciences, The University of Western Australia, WA, Australia., Filshie R; Department of Haematology, St Vincent's Hospital, VIC, Australia.; Faculty of Medicine, Dentisty & Health Sciences, The University of Melbourne, VIC, Australia., Purtill D; Department of Haematology, PathWest Laboratory Medicine, WA, Australia.; Department of Haematology, Fiona Stanley Hospital, WA, Australia., Sia H; Department of Haematology, Tweed Valley Hospital, NSW, Australia., Enjeti AK; Department of Haematology, Calvary Mater Hospital, NSW, Australia.; School of Medicine & Public Health, The University of Newcastle, NSW, Australia., Brown C; Faculty of Medicine & Health, The University of Sydney, NSW, Australia.; Institute of Haematology, Royal Prince Alfred Hospital, NSW, Australia., Murphy N; Department of Haematology, Royal Hobart Hospital, TAS, Australia., Curnow J; Faculty of Medicine & Health, The University of Sydney, NSW, Australia.; Department of Haematology, Westmead Hospital, NSW, Australia., Lee K; Department of Haematology, Concord Repatriation General Hospital, NSW, Australia.; Faculty of Medicine & Health, The University of Sydney, NSW, Australia., Gandhi MK; Mater Research Institute, The University of Queensland, QLD, Australia., Walia M; Australasian Leukaemia & Lymphoma Group, VIC, Australia., Butcher BE; WriteSource Medical Pty Ltd, NSW, Australia.; School of Biomedical Sciences, University of New South Wales, NSW, Australia., Trotman J; Department of Haematology, Concord Repatriation General Hospital, NSW, Australia.; Faculty of Medicine & Health, The University of Sydney, NSW, Australia.

Publikováno v: Blood advances [Blood Adv] 2024 Nov 12; Vol. 8 (21), pp. 5674-5682.

Indolent relapse after initial aggressive B-cell lymphoma: a single institution experience in the rituximab era.

Autor: Fasser D; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.; The University of Western Australia Medical School, Perth, Australia., Lewis K; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Leslie C; Department of Anatomical Pathology, PathWest Laboratory Medicine, Nedlands, Australia., Cull G; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Radeski D; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Augustson B; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Howman R; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Joske D; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Crawford J; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Grove C; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia., Cheah CY; Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.; The University of Western Australia Medical School, Perth, Australia.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Oct 18, pp. 1-4. Date of Electronic Publication: 2024 Oct 18.

Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study.

Autor: Barraclough A; Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Victoria, Australia; Fiona Stanley Hospital, Western Australia., Agrawal S; Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Victoria, Australia; Prince of Wales Hospital, New South Wales., Talaulikar D; Canberra Health Services, Australian Capital Territory, Australia; College of Health and Medicine, Australian National University, Australian Capital Territory., Chong G; Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Victoria, Australia; Ballarat Regional Integrated Cancer Centre, Ballarat Health Services, Victoria., Yoo E; Fiona Stanley Hospital, Western Australia, Australia; Sir Charles Gairdner Hospital, Western Australia., Cheah CY; Sir Charles Gairdner Hospital, Western Australia, Australia; Medical School, University of Western Australia, Western Australia., Franco N; Canberra Health Services, Australian Capital Territory, Australia; College of Health and Medicine, Australian National University, Australian Capital Territory., Nguyen B; Fiona Stanley Hospital, Western Australia., Mutsando H; Toowoomba Hospital, Queensland, Australia; University of Queensland Rural Clinical School, Queensland., Tahir F; Concord Repatriation General Hospital, University of Sydney, New South Wales., Trotman J; Concord Repatriation General Hospital, University of Sydney, New South Wales., Huang J; School of Clinical Sciences at Monash Health, Monash University, Victoria., Keane C; Princess Alexandra Hospital, Queensland., Lincoln M; Alfred Hospital, Victoria., Cochrane T; Gold Coast University Hospital, Queensland, Australia; School of Medicine, Griffith University, Queensland., Johnston AM; Royal Hobart Hospital, Tasmania., Dickinson M; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Victoria., Opat S; School of Clinical Sciences at Monash Health, Monash University, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Victoria., McQuilten ZK; School of Clinical Sciences at Monash Health, Monash University, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Victoria., Wood EM; School of Clinical Sciences at Monash Health, Monash University, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Victoria., St George G; School of Public Health and Preventive Medicine, Monash University, Victoria., Hawkes EA; Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Victoria. eliza.hawkes@onjcri.org.au.

Publikováno v: Haematologica [Haematologica] 2024 Oct 01; Vol. 109 (10), pp. 3338-3345. Date of Electronic Publication: 2024 Oct 01.